AdvaMed appointment
This article was originally published in The Gray Sheet
Executive Summary
Ann-Marie Lynch, most recently an advisor in the HHS Office of the Assistant Secretary for Planning and Evaluation, will begin Oct. 24 as the trade association's executive VP-Payment & Healthcare Delivery. Priorities will include initiatives in the areas of gainsharing, value-based purchasing and reimbursement rescaling for diagnostics. Lynch has served as staff director for the House Ways & Means Health Subcommittee and as an economist in the Bureau of Policy Development of the Healthcare Financing Administration, the precursor to CMS...
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.